Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Resomelagon by SynAct Pharma for Rheumatoid Arthritis: Likelihood of Approval
Resomelagon is under clinical development by SynAct Pharma and currently in Phase II for Rheumatoid Arthritis. According to GlobalData, Phase...